Argentine companies operating in the same pharmaceuticals: major industry
The list below has Argentine companies that operate under the same industry, pharmaceuticals: major. The list helps track their performance, income statement, and more. Sorted by any necessary metric, it can show the most expensive stocks of the industry such as ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 or those with the best price dynamics like GSK PLC CEDEAR EACH REPR 1/4 ADR (USD), thus assisting in designing strategies of any focus.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 914.02 T ARS | 19,125 ARS | +1.86% | 4.29 K | 0.84 | 90.80 | 210.62 ARS | +235.69% | 0.31% | Health technology | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 914.02 T ARS | 16.40 USD | +2.18% | 330 | 1.34 | 83.55 | 210.62 ARS | +167.86% | 0.31% | Health technology | — |
 DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)DR | 440.54 T ARS | 1,300 ARS | 0.00% | 6 | 1.20 | — | — | — | — | Health technology | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 440.54 T ARS | 12,475 ARS | +0.81% | 5.83 K | 0.20 | 20.89 | 597.27 ARS | +206.49% | 1.68% | Health technology | — |
| DJN3DJOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 440.54 T ARS | 1.300 USD | 0.00% | 2 | 0.00 | — | — | — | — | Health technology | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 440.54 T ARS | 10.75 USD | +1.42% | 347 | 0.42 | 19.31 | 597.27 ARS | +144.56% | 1.68% | Health technology | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 411.11 T ARS | 23,275 ARS | +0.54% | 913 | 0.85 | 10.34 | 2,251.52 ARS | +58.86% | 2.16% | Health technology | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 411.11 T ARS | 19.50 USD | −1.52% | 58 | 0.76 | 9.29 | 2,251.52 ARS | +26.76% | 2.16% | Health technology | — |
 AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25DR | 259 T ARS | 42,750 ARS | +0.06% | 115 | 0.13 | 43.75 | 977.22 ARS | +146.53% | 1.64% | Health technology | — |
| AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 259 T ARS | 36.55 USD | +5.18% | 7 | 0.30 | 40.13 | 977.22 ARS | +96.72% | 1.64% | Health technology | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 253.88 T ARS | 33,600 ARS | −0.96% | 135 | 3.52 | 4.89 | 6,872.32 ARS | +10.89% | 3.72% | Health technology | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 253.88 T ARS | 26.20 USD | −1.13% | 4 | 0.75 | 4.09 | 6,872.32 ARS | −11.51% | 3.72% | Health technology | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 245.1 T ARS | 20,325 ARS | +0.62% | 600 | 0.24 | 15.26 | 1,332.07 ARS | +380.66% | 1.97% | Health technology | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 245.1 T ARS | 17.20 USD | +3.61% | 2 | 0.01 | 13.85 | 1,332.07 ARS | +283.54% | 1.97% | Health technology | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 160.71 T ARS | 7,280 ARS | +2.54% | 20.56 K | 0.88 | 21.38 | 340.44 ARS | +754.74% | 3.71% | Health technology | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 160.71 T ARS | 6.22 USD | +2.64% | 3.29 K | 1.33 | 19.60 | 340.44 ARS | +582.03% | 3.71% | Health technology | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 120.51 T ARS | 19,775 ARS | +1.15% | 866 | 2.70 | 22.81 | 866.77 ARS | — | 3.41% | Health technology | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 91.01 T ARS | 11,800 ARS | +2.16% | 1.35 K | 3.84 | 24.83 | 475.21 ARS | +66.14% | 2.85% | Health technology | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 91.01 T ARS | 10.05 USD | +6.35% | 490 | 22.90 | 22.69 | 475.21 ARS | +32.57% | 2.85% | Health technology | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 21.2 T ARS | 11,100 ARS | 0.00% | 225 | 0.61 | 15.03 | 738.44 ARS | +152.71% | 0.00% | Health technology | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 21.2 T ARS | 9.70 USD | +1.89% | 12 | 0.61 | 14.09 | 738.44 ARS | +101.65% | 0.00% | Health technology | — |
 RICHLABORATORIOS RICHMOND SACIF | 117.9 B ARS | 1,460 ARS | +1.74% | 19.94 K | 1.67 | 5.56 | 262.78 ARS | — | 0.00% | Health technology | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 3.78 B ARS | 88.7 ARS | −4.11% | 5.95 K | 0.88 | 20.78 | 4.27 ARS | +64.50% | 0.00% | Health technology | — |